Assessing an Anti-CD46 ADC – Pre-Clinical & Phase 1 Clinical Results In mCRPC

Time: 12:30 pm
day: Track C - Day 2

Details:

  • Sharing novel immunomodulatory target
  • Presenting pre-clinical development programme
  • Phase 1a/1b Clinical Results in mCRPC

Speakers: